Shen Wei & Shen Dingming. COMBINED ASSAY OF SERUM TUMOR ENZYME MARKERS IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA. [J]. Journal of Chongqing Medical University (4):261-266(1989)
Shen Wei & Shen Dingming. COMBINED ASSAY OF SERUM TUMOR ENZYME MARKERS IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA. [J]. Journal of Chongqing Medical University (4):261-266(1989) DOI: 10.13406/j.cnki.cyxb.1989.04.001.
COMBINED ASSAY OF SERUM TUMOR ENZYME MARKERS IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA
In order to evaluate combined serum tumor enzyme determinations in the diagnosis of hepatocellular carcinoma (HCC)
four tumor markers including gamma-glutamyl tran- speptidase isoenzyme (r-GT-II)
alkaline phosphatese isoenzyme (ALP-I)
the ratio of the two aldolase activities
fructose-1
6-diphosphoaldolase and fructose-1-phosphoaldo-lase (FDP/FIP) and a-L-fucosidase (AFU) were concomitantly determined in 59 patients with HCC
97 patients with various liver diseases and gastrointestinal tumors. The results revealed that: (l)r-GT-II
ALP-I
FDP/FIP and AFU level were increased significantly in HCC (P<0.01); (2) The diagnostic sensitivity and specificity of these markers in HCC were r-GT-II(79.7%)>AFU(78.8%)>FDP/FIP(61%)>ALP-I(16.95%) and ALP-I(100%) >r-GT-II(92.l%)>AFU(90.9%)>FDP/FIP (88.8%)
respectively; (3) The diagnostic positivity of combination assay was 80.0% in low or negative AFP producing HCC
while 95.7% in those with elevated AFP. Our data suggested that the combination assay of serum tumor enzyme markers was valuable in the diagnosis of HCC
EVALUATION OF SERUM FUCOSYLATED AFP ASSAY IN THE DIAGNOSIS OF PRIMARY HEPATIC CARCINOMA
Evaluation of serum lectin-reactive α-fetoprotein affinity blotting method and the qualitative,quantitative analysis of γ-glutamyl transpeptidase isozyme Ⅱ in the diagnosis of primary hepatic carcinoma